Identifying the sentinel node during axillary dissection for breast cancer

被引:0
|
作者
Salmon, RJ [1 ]
Fried, D [1 ]
机构
[1] Inst Curie, F-75248 Paris 05, France
来源
PRESSE MEDICALE | 1998年 / 27卷 / 11期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: The sentinel node is defined as the first-line axillary lymphatic drainage node in breast cancer. If the sentinel node can be identified. during axillary dissection for breast cancer, resection could be limited reducing subsquent morbidity. However, before modifying the standard dissection procedure, it is important to prove that the sentinel node is representative of the metastatic status of other axillary nodes. PATIENTS AND METHODS: Between March and December 1996, 86 patients (mean age 58 years, range 32-82) underwent amputation (n = 20), tumorectomy with dissection (n = 56) or tumorectomy followed by secondary dissection (n = 10) for breast cancer. Ten mi of diluted patent blue was injected either into the peripheral portion of the tumor or the tumorectomy cavity. Node dissection was performed 10 to 20 minutes after injection. The blue sentinel node was identified prior to standard dissection. RESULTS: A mean 12 nodes were removed (range 4-21), Seventy-nine sentinel nodes were identified (91%) and in 7 cases (8%) a sentinel node could not be identified. In 7 other cases the sentinel node was a false negative, i.e. non malignant despite metastases in other dissected nodes. In all the other cases, the status of the sentinel node predicted the status of the other nodes, i.e. a non-metastatic sentinel node associated with other metastatic nodes. Finally, in 7 cases, the sentinel node was the only invaded node among the nodes dissected. During the last 3 months cri the study, the sentinel node was identified in 100% of the cases and was representative of the overall dissection, CONCLUSION: Identifying the sentinel node is an alternative to standard axillary node dissection procedures, The method requires a training period and identification can be improved with radioimmunologic guidance. Patient selection within the framwork of a rigorous multidisciplinary protocol is indispensable. A nationwide study is currently being conduced to validate these preliminary results.
引用
收藏
页码:509 / 512
页数:4
相关论文
共 50 条
  • [11] Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer
    Palesty, JA
    Foster, JM
    Hurd, TC
    Watroba, N
    Rezaishiraz, H
    Edge, SB
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (02) : 129 - 132
  • [12] Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node
    Khakpour, N
    Hunt, KK
    Kuerer, HM
    Yi, M
    Meric-Bernstam, F
    Ross, MI
    Lucci, A
    AMERICAN JOURNAL OF SURGERY, 2005, 190 (04): : 598 - 601
  • [13] Axillary lymph node dissection in breast cancer patients after sentinel node biopsy
    Jessing, Christina
    Langhans, Linnea
    Jensen, Maj-Britt
    Talman, Maj-Lis
    Tvedskov, Tove Filtenborg
    Kroman, Niels
    ACTA ONCOLOGICA, 2018, 57 (01) : 166 - 169
  • [14] Axillary lymph node dissection versus the sentinel lymph node technique in breast cancer
    Seigler, HF
    ANNALS OF SURGERY, 2004, 240 (01) : 7 - 8
  • [15] Axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases
    Gomez Dorronsoro, L. M.
    Aizcorbe Garralda, M.
    De Pablo Angel, Sanz M.
    Dominguez, F.
    Trujillo, R.
    De Miguel Medina, C.
    Ruiz De Azua, Y.
    Gonzalez Alvarez, G.
    VIRCHOWS ARCHIV, 2009, 455 : 94 - 94
  • [16] A randomized trial of axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node
    Galimberti, V.
    de Almeida, R. Cecilio Sahium
    Rodriguez, J.
    Pagani, G.
    Sagona, A.
    Burgoa, L.
    Scarano, E.
    Peruzzotti, G.
    Colleoni, M.
    Goldhirsch, A.
    BREAST, 2007, 16 : S30 - S31
  • [17] Axillary recurrence in 292 breast cancer patients with negative sentinel node biopsy and no axillary dissection
    Sinko, M.
    Rajtar, M.
    Cserni, G.
    Boross, G.
    Wolde, E. Tekle
    Ambrozay, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S272 - S272
  • [18] Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer
    Veronesi, U
    Galimberti, V
    Zurrida, S
    Pigatto, F
    Veronesi, P
    Robertson, C
    Paganelli, G
    Sciascia, V
    Viale, G
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (04) : 454 - 458
  • [19] Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer
    Nwariaku, FE
    Euhus, DM
    Beitsch, PD
    Clifford, E
    Erdman, W
    Mathews, D
    Albores-Saavedra, J
    Leitch, MA
    Peters, GN
    AMERICAN JOURNAL OF SURGERY, 1998, 176 (06): : 529 - 531
  • [20] Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer
    Fayda, Merdan
    Karanlik, Hasan
    LANCET ONCOLOGY, 2013, 14 (07): : E250 - E250